4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001415889-22-008784
Options or other derivatives
- PRES. DIAGNOSTICS & GENOM acquired 14,407 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelderman Kim PRES. DIAGNOSTICS & GENOM | 2022-08-15 | Grant or award · Restricted Stock Units | +1,746 | 1,746 | D | ||
| Kelderman Kim PRES. DIAGNOSTICS & GENOM | 2022-08-15 | Grant or award · Stock Options (Right to Buy) | +5,426 | 5,426 | D | ||
| Kelderman Kim PRES. DIAGNOSTICS & GENOM | 2022-08-15 | Grant or award · Stock Options (Right to Buy) | +7,235 | 7,235 | D | ||
Loading xslF345X03/form4-08172022_020800.xml…